you can measure platelet activation by their binding to monocytes which is a marker for heart risk, but cell cell aggregation should not be confused with platelet activation as it can occur independently particularly when washing and centrifugation steps are part of the sample preparation. You can measure that separately by a range of surface markers shown on the platelet, but you have to be aware of the problems of sampling and sample storage to prevent the platelets going off. When measuring platelet - leukocyte aggregation one has to distinguish true binding events from coincident events. In case of heart risk the binding to the monocots should be specific, e.g be higher in percentage than for the other cells, easies seen in a log side scatter versus the respective CD markers. Not having researched the field in detail but looked ad adhesion molecules some time ago I would just want to make people aware that adhesion molecule expression is a question of anticoagulant and time and temperature, and so should be cell adhesion. There are a lot of confusing articles out about the phenomenon of cell to platelet aggregation that lack systematic controls. Regards Gerhard -----Original Message----- From: KurtzJ@usa.redcross.org [mailto:KurtzJ@usa.redcross.org] Sent: 07 November 2005 15:17 To: Cytometry Mailing List Subject: [ Platelet activation question ] I would like to know is anyone out there has a procedure to measusare platelet activation using leukocyte aggregates? I also have seen that the measurement of leukocyte aggregates is usually done for invivo studies, is this also an appropriate measurement for invitro work? Thanks, any comments would be appreciated. Jim KurtzReceived on Tue Nov 8 15:18:00 2005
This archive was generated by hypermail 2.1.8 : Sat Jan 14 2006 - 22:03:58 EST